MoneyWorks4Me

Mercury Laboratories - Quaterly Results

09 Aug 2022 Evaluate
The revenue for the June 2022 quarter is pegged at Rs. 175.99 millions, about 13.37% up against Rs. 155.23 millions recorded during the year-ago period.A slim rise of 17.42% was recorded in the Net profit for the quarter ended June 2022 to Rs. 14.63  millions  From Rs. 12.46 millions.OP of the company witnessed a marginal growth to 27.60 millions from 24.12 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 175.99 155.23 13.37 175.99 155.23 13.37 579.24 686.02 -15.57
Other Income 4.92 1.29 281.40 4.92 1.29 281.40 8.16 8.80 -7.27
PBIDT 27.60 24.12 14.43 27.60 24.12 14.43 79.30 104.72 -24.27
Interest 0.94 1.10 -14.55 0.94 1.10 -14.55 4.46 6.41 -30.42
PBDT 26.66 23.02 15.81 26.66 23.02 15.81 76.12 98.31 -22.57
Depreciation 6.15 5.10 20.59 6.15 5.10 20.59 24.53 19.21 27.69
PBT 20.51 17.92 14.45 20.51 17.92 14.45 51.59 79.10 -34.78
TAX 5.88 5.46 7.69 5.88 5.46 7.69 14.73 25.72 -42.73
Deferred Tax -0.93 0.62 -250.00 -0.93 0.62 -250.00 1.02 3.88 -73.71
PAT 14.63 12.46 17.42 14.63 12.46 17.42 36.86 53.38 -30.95
Equity 12.00 12.00 0.00 12.00 12.00 0.00 12.00 12.00 0.00
PBIDTM(%) 15.68 15.54 0.93 15.68 15.54 0.93 13.69 15.26 -10.31
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1244.50
Cipla 1384.85
Lupin 2076.00
Zydus Lifesciences 1214.25
View more..